secwatch.observer — SEC 8-K summary
======================================

Issuer:     TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
CIK:        0000818686
Form:       8-K
Filed at:   2023-06-15T23:59:59+00:00
Accession:  0001193125-23-167868
Event type: other_material
Sentiment:  negative
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Teva shareholders reject advisory vote on executive compensation at 2023 annual meeting
--------------------------------------------------------------------------------

- Elected directors Sol J. Barer and Janet S. Vergis with ~490M and ~498M votes for, respectively.
- Say-on-pay proposal failed: 319.2M for, 324.5M against, showing majority disapproval.
- Auditor Kesselman & Kesselman (PwC) ratified with 712.7M votes for, 35.8M against.
- Approximately 103.9M broker non-votes on director and say-on-pay items.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/818686/000119312523167868/0001193125-23-167868-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/818686/000119312523167868/d514530d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-167868

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer